NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
172 hedge funds and large institutions have $1.73B invested in NxStage Medical Inc. in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 24 closing their positions.
83% more funds holding in top 10
Funds holding in top 10: 6 → 11 (+5)
7% more capital invested
Capital invested by funds: $1.61B → $1.73B (+$119M)
2% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 58
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
2% less funds holding
Funds holding: 175 → 172 (-3)
59% less call options, than puts
Call options by funds: $1.18M | Put options by funds: $2.86M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$46.5M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$31.3M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$23.1M |
| 4 |
MP
Manikay Partners
New York
|
+$19.9M |
| 5 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
+$18.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIC
Water Island Capital
New York
|
-$25.9M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$16.8M |
| 3 |
MCP
Moab Capital Partners
Southampton,
New York
|
-$15.1M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$14.1M |
| 5 |
Flossbach Von Storch
Cologne,
Germany
|
-$10.5M |
NXTM Hedge Fund Activity: Q4 2018 in Review
172 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2018, worth a combined $1.73B — up 7.4% from $1.61B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of NXTM and 22 opened new positions — a net loss of 2 holders — while 58 trimmed existing stakes and 57 added.
The largest buyer was Citadel Advisors, adding an estimated $46.5M. The largest seller was Water Island Capital, cutting an estimated $25.9M.
- 172 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2018, down from 175 in Q3 2018.
- Funds reported $1.73B of NxStage Medical Inc. stock for Q4 2018, up 7.4% quarter-over-quarter.
- 22 funds opened new NxStage Medical Inc. positions in Q4 2018 and 24 closed out, a net change of -2 holders.
- The largest NxStage Medical Inc. buyer in Q4 2018 was Citadel Advisors, an estimated $46.5M added.
- The largest NxStage Medical Inc. seller in Q4 2018 was Water Island Capital, an estimated $25.9M sold.
Based on aggregated 13F filings for Q4 2018.